The cancer battle - how smaller companies are making big advancements in treatments for solid tumors

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - august 12, 2024) - investorideas.com, a go-to investing platform covering biotech and medical technology issues a snapshot on recent news and developments for the treatment of solid cancer tumors, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. read the full article at investorideas.com https://www.investorideas.com/news/2024/biotech/08120cancer-battle.asp the brainy insights estimates that the usd 222.71 billion solid tumor therapeutics market will reach usd 885.44 billion by 2033.
AEMD Ratings Summary
AEMD Quant Ranking